CFTR and cystic fibrosis: Lumacaftor (Vx-809) (Figure 2) is the first drug approved for the treatment of cystic fibrosis in patients homozygous for the most common cystic fibrosis transmembrane Conductance Regulator (CFTR), mutated F508del-CFTR.